icotinib hydrochloride

DRUG2 trials

Sponsors

Yuhong Li, Roswell Park Cancer Institute

Conditions

Esophageal Squamous Cell CarcinomaUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Icotinib Hydrochloride in Treating Patients With Advanced Cancers

WithdrawnNCT02033148

Roswell Park Cancer InstituteUnspecified Adult Solid Tumor, Protocol Specific

Start: 2014-08-31Updated: 2014-11-05

Phase 2

Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy

CompletedNCT01973725

Yuhong LiEsophageal Squamous Cell Carcinoma

Start: 2013-10-31End: 2018-12-31Updated: 2023-02-17